Your browser doesn't support javascript.
loading
Acquired generalized lipodystrophy under immune checkpoint inhibition.
Haddad, N; Vidal-Trecan, T; Baroudjian, B; Zagdanski, A-M; Arangalage, D; Battistella, M; Gautier, J-F; Lebbe, C; Delyon, J.
Affiliation
  • Haddad N; Department of Dermatology, AP-HP Saint-Louis Hospital, F-75010, Paris, France.
  • Vidal-Trecan T; Department of Endocrinology, AP-HP Lariboisière Hospital, F-75010, Paris, France.
  • Baroudjian B; Department of Dermatology, AP-HP Saint-Louis Hospital, F-75010, Paris, France.
  • Zagdanski AM; Department of Radiology, AP-HP Saint-Louis Hospital, F-75010, Paris, France.
  • Arangalage D; Université de Paris, Paris, France.
  • Battistella M; Department of Cardiology, AP-HP Bichat Hospital, F-75018, Paris, France.
  • Gautier JF; Université de Paris, INSERM U1148, F-75018, Paris, France.
  • Lebbe C; Department of Pathology, AP-HP Saint-Louis Hospital, F-75010, Paris, France.
  • Delyon J; Université de Paris, INSERM U1165, F-75010, Paris, France.
Br J Dermatol ; 182(2): 477-480, 2020 02.
Article in En | MEDLINE | ID: mdl-31077337
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lipodystrophy, Congenital Generalized / Melanoma Limits: Humans / Middle aged Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lipodystrophy, Congenital Generalized / Melanoma Limits: Humans / Middle aged Language: En Year: 2020 Type: Article